Providence Launches 12 Epic AI Tools
Providence, a 51‑hospital system, upgraded its Epic electronic health record in April and launched 12 AI‑driven tools across inpatient, ambulatory and revenue‑cycle workflows. The suite includes an AI Text Assistant that converts clinical notes into patient‑friendly language, Inpatient Insights that auto‑generates admission overviews, and Draft Hospital Course that drafts discharge summaries. The rollout is part of the system’s Project Pixel, which embeds governance, guardrails and physician partnership. The initiative will be highlighted at Becker’s IT + Revenue Cycle Conference in September.
Protecting Innovation for Psychedelic Therapies Fast-Tracked Under New Executive Order
President Donald J. Trump signed an executive order that fast‑tracks FDA approval for breakthrough psychedelic therapies targeting serious mental illness. The order creates a Commissioner’s National Priority Voucher program, establishes pre‑approval patient access pathways, and earmarks $50 million in federal funding...
HCA Still Expects up to $900M Hit From ACA Headwinds
HCA Healthcare reaffirmed its 2026 outlook, still expecting a $600 million‑$900 million EBITDA headwind from changes to the ACA exchange, including the loss of enhanced subsidies. The first‑quarter results showed a $150 million EBITDA drag as exchange‑related admissions fell roughly 15% year‑over‑year, while...
DOJ Asks For Stay Pending Appeal In ACIP Court Case
The U.S. Department of Justice has asked a federal appeals court to pause all further action in a lawsuit filed by medical organizations challenging recent changes to the Advisory Committee on Immunization Practices (ACIP). The request seeks a stay pending...
EU Biotech Act: The European Commission’s Landmark Proposal to Strengthen Biotechnology in Europe
On December 2025 the European Commission unveiled the European Biotech Act, a sweeping proposal aimed at cementing the EU’s position as a global biotech leader against the United States and China. The Act introduces fast‑track regulatory pathways, a strategic‑project framework...
Re: England Athletics Promotion of Medical Knee Procedure to Runners on Eve of London Marathon Is Condemned by Experts
England Athletics recently promoted Arthrosamid, a Class IIb implantable knee device, to runners ahead of the London Marathon. The product, marketed as a "drug," bypasses many safety tests because it carries a CE mark that allows manufacturer self‑certification. A UK...
Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy
The GLP‑1 drug class now reaches roughly 12% of U.S. adults, making it one of the fastest‑adopted therapies in recent history. Critics argue that weight alone is an inadequate measure of success, prompting Hone Health to partner with imaging startup...
FDA Awards Three Priority Review Vouchers For Psychedelics
On April 24, 2026 the FDA announced it will issue three priority review vouchers to companies developing psychedelic therapies. The vouchers cover two psilocybin programs targeting treatment‑resistant and major depressive disorder, and a methylone program for post‑traumatic stress disorder. The...
Hair Loss in Women ‘Increasingly Mentioned’
Hair loss in women is becoming a more frequent concern, with the Cleveland Clinic estimating that 30 million U.S. women are affected and more than half will notice visible thinning. At the ACP Internal Medicine Meeting, dermatologist Dr. Ashley Wentworth highlighted...
Ontario Hospitals Announce Job Cuts, Nearly Three-Quarters of Hospitals in Deficit
Ontario hospitals are slashing jobs as financial deficits widen, with more than 70% of facilities forecasting shortfalls. A $1.1 billion CAD ($800 million USD) provincial boost proved insufficient, prompting The Ottawa Hospital to cut about 3% of its workforce through early retirements...
Eliminating Patient Hold Times: Catholic Health’s Rapid Deployment of Voice AI
Catholic Health tackled low MyChart adoption and costly call‑center inefficiencies by deploying Notable’s voice AI in its Help Desk. The AI agents lifted call containment from a 30% target to 64%, cutting monthly call costs by $60,000 and projecting $360,000...
FDA Unveils Three Psychedelic-Focused Commissioner Vouchers
The U.S. Food and Drug Administration announced it has issued fast‑track “commissioner vouchers” to three psychedelic‑focused companies. The agency withheld the identities of the sponsors, a move that surprised investors and analysts. The vouchers are designed to expedite regulatory review,...
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs, the DeepMind spinoff behind AlphaFold, announced that its AI‑designed drug candidates will soon enter human clinical trials. The company’s new IsoDDE engine claims to double the accuracy of AlphaFold 3 in predicting protein‑small‑molecule interactions. Partnerships with Eli Lilly and Novartis...
Brooks-TLC Workers Ratify Contract Extension
Members of 1199SEIU United Healthcare Workers East at Brooks‑TLC Hospital System ratified a one‑year contract extension covering more than 160 employees. The agreement, effective until April 30, 2027, delivers a 3.75% wage increase and targeted hourly bumps for surgical technicians,...
Vanderbilt Chief Heads to Dana-Farber
Vanderbilt Health’s system surgeon‑in‑chief Seth Karp will leave on Oct. 15 to become surgeon‑in‑chief at Boston’s Dana‑Farber Cancer Institute. He will simultaneously chair the Department of Surgery at Beth Israel Deaconess Medical Center. The move coincides with Dana‑Farber’s $1.68 billion partnership with...
Washington Hospital Restructures Clinic, Ends Pain Management Services
East Adams Rural Healthcare (EARH) in Ritzville, Washington, is resetting its rural health clinic after a near‑closure caused by financial strain. The new model, effective June 1, will staff the clinic with a single provider on‑site each day, supported by a...
The Quiet Gaps in ED Performance Data — and What Execs Can Do About Them
Hospital leaders now have unprecedented access to emergency department (ED) data, but without adjusting for patient acuity and using appropriate peer groups, the information can be misleading. The CDC’s federal ED utilization report ended in 2022, leaving a fragmented landscape...
Birthday Cards Are Just the Start: Inside AdventHealth’s Hospitality Strategy
AdventHealth launched its Health Parks—a 36,000‑square‑foot, one‑stop‑shop model that bundles lab, imaging, primary care and specialty services under a single roof. The integrated layout lets 1‑2 of every 3 patients receive multiple services in one visit, reducing the need for...
Designer Baby Companies Are in Turmoil
Two high‑profile germline‑editing startups—Bootstrap Bio and Manhattan Genomics—have ceased operations within a year of launching. Bootstrap Bio folded after running out of capital and was further tarnished by the federal arrest of its chief science officer on child‑sex‑trafficking charges. Manhattan...
No Benefit, Maybe Harm, With Invasive Approach in Frail NSTEMI Patients
Analysis of the SENIOR‑RITA trial’s frailty sub‑study shows that severely frail NSTEMI patients do not benefit from routine invasive angiography and revascularization. Over a median 4.1‑year follow‑up, the composite of cardiovascular death or non‑fatal MI occurred in 37.7% of frail...
Biopharma Money Raised: Jan. 1-April 23, 2026
Regeneron’s Otarmeni, a gene‑therapy for congenital hearing loss, earned FDA accelerated approval and will be provided free of charge, marking a rare zero‑cost gene‑therapy launch. At AACR 2026, researchers highlighted breakthroughs in minimal residual disease (MRD) detection that sharpen relapse...
Many High-Risk Pregnant Patients Still Miss Out on Guideline-Recommended Care
New research from the Mass General Brigham system reveals that only about a quarter of high‑risk pregnant patients receive the guideline‑recommended low‑dose aspirin to prevent preeclampsia. The study, covering more than 60,000 pregnancies from 2013 to 2023, shows aspirin use...
Residency Fill Rates Worsen for Primary Care: 20 Stats to Know
The Trilliant Health report shows primary‑care residency fill rates falling despite a surge in medical‑school applications and residency slots. In the 2026 match, family medicine was 16.4% unfilled, pediatrics 5.6% and internal medicine 4.6%, with the overall primary‑care fill rate...
The Specialty Facing a Million Dollar Gender Pay Gap
A Yale‑led study of the AAMC Faculty Salary Survey (2016‑2024) shows that female ophthalmologists in academia earn less than male peers at every rank. Women now represent a slight majority of assistant professors but only 30% of full professors and...
Edwards Raises 2026 Forecast as TAVR Sales Surge
Edwards Lifesciences raised its full‑year 2026 sales‑growth outlook to 9‑11% after reporting a 16.7% jump in first‑quarter revenue to $1.65 billion, driven by a 14.4% increase in TAVR sales to $1.2 billion. The company also lifted its TAVR growth forecast to 7‑9%...
Postmarketing Requirements and Commitments: Reports
The FDA publishes annual reports in the Federal Register detailing the status of post‑marketing requirements (PMRs) and commitments (PMCs) for drugs and biologics, covering both CDER and CBER. These reports summarize data from internal databases and are updated quarterly on...
WHO Prequalifies First-Ever Malaria Treatment for Newborns and Infants, Adds New Diagnostic Tests
The World Health Organization has prequalified the first antimalarial drug formulated specifically for newborns and infants weighing 2‑5 kg—artemether‑lumefantrine—enabling public‑sector procurement for an estimated 30 million babies born each year in malaria‑endemic Africa. The agency also prequalified three rapid diagnostic tests that...
Pressure Points: Aristeia on Its New Battlefield Tourniquet
Aristeia introduced its Generation 8 battlefield tourniquet, aimed at military, parapublic and civilian agencies. The new device features a slimmer polymer‑composite band, a single‑hand pull‑to‑apply mechanism and visual placement cues, delivering about a 30 % faster application than the previous model. Independent...
AAN 2026: Tavapadon Post-Hoc Analysis Strengthens Its D1/D5 Agonist Pitch
At the 2026 American Academy of Neurology meeting, AbbVie unveiled post‑hoc results from its Phase III TEMPO‑1 and TEMPO‑2 trials of tavapadon, a once‑daily oral D1/D5 partial agonist for early Parkinson’s disease. The analysis showed statistically significant improvements in seven of...
Photo of the Week: Airway Trauma Training
EMS1 staff, a team of seasoned writers, editors, and emergency medical professionals, deliver timely, actionable content for pre‑hospital care providers. The outlet emphasizes breaking news, expert advice, and practical tools to improve EMT and paramedic performance. It promotes free subscription...
Reprogrammed Cardiomyocytes Soften the Blow in Heart Attack
A recent study published in the Journal of Molecular and Cellular Cardiology demonstrates that partial reprogramming of mouse cardiomyocytes with three Yamanaka factors (OCT4, SOX2, KLF4 – OSK) enables the cells to complete cytokinesis after a heart attack. By dismantling...
AAN 2026: Head-to-Head Trial Shows Superiority of Qulipta for Migraine Prevention
AbbVie presented Phase IIIb TEMPLE trial data at AAN 2026, showing its oral gepant Qulipta outperforms topiramate in migraine prevention. Over 24 weeks, Qulipta had a 12.1% discontinuation rate versus 29.6% for topiramate and achieved a 73.7% responder rate (>50% reduction in...
JLL Launches Healthcare Facility Accreditation Program
JLL’s healthcare division unveiled the Accreditation Lifecycle Program (ALG), a multi‑year compliance solution designed to keep hospitals continuously ready for The Joint Commission’s new Accreditation 360 standards. The platform aligns with the Joint Commission’s cycle, centralizing drawings, inspections and audit trails...
Sanofi MS Drug Rejected in US Gets an Endorsement in Europe
Sanofi’s experimental multiple‑sclerosis drug tolebrutinib, marketed as Cenrifki, received a positive recommendation from the European Medicines Agency for secondary progressive MS, after the U.S. FDA rejected it earlier this year. The EMA’s endorsement paves the way for a final approval...
HIMSSCast: Medicaid as a Health IT Innovation Engine
Dr. Christopher R. Cogle argues that Medicaid, covering over 80 million Americans, functions as a powerful health‑IT innovation engine. Designing systems for the most complex, vulnerable populations has spurred advances in data infrastructure, managed‑care oversight, and population‑health analytics. The HIMSSCast episode...
AI May Be Approaching a New Phase in Healthcare, on Two Fronts
Physicians are adopting Anthropic's agentic AI tool Claude Code to build custom clinical applications, signaling a shift toward doctor‑led software development within health systems. The latest frontier model, Claude Mythos, can identify code vulnerabilities, prompting security leaders to warn of...
Official Statistics: Mefloquine (Larium) Prescribing in the UK Armed Forces: 12 September 2016 to 31 March 2026
The UK Ministry of Defence has published official statistics on mefloquine (Larium) prescribing within the armed forces from September 2016 through March 2026, following a policy shift introduced in 2016. The data reveal a steady decline in mefloquine use, increased...
Health Plans Adopt Standardized Approach to Prior Authorization
Health plans, including UnitedHealthcare, Cigna, Aetna, Humana and major Blue Cross entities, announced a voluntary initiative to use a standardized electronic prior‑authorization (e‑PA) format beginning Jan. 1, 2027. The new standard will cover common services such as orthopedic surgery, CT scans and...
How Northwell Health Engages Specialists in Value-Based Care
Northwell Health, overseeing 29 hospitals and 800+ ambulatory sites, is tackling the specialist‑centric gap in value‑based care. While most ACO contracts focus on primary‑care metrics, specialists account for the bulk of utilization costs and patient complexity. To bridge this, Northwell...
J&J Lands CE Mark for Surgical Stapler that Works with Ottava Robot
Johnson & Johnson has secured a CE mark for its Ethicon 4000 surgical stapler, enabling European surgeons to use the device in open and laparoscopic procedures now. The stapler is engineered to work with J&J’s upcoming Ottava robotic platform, which has...
Drug Digest: Examining the Architecture of Next-Gen Biotherapeutic Modalities
Minaris Advanced Therapies’ chief commercial and technology officer, Dr. Eytan Abraham, discussed how multifunctional biotherapeutics are merging antibodies, ADCs and engineered cells to create more precise, personalized treatments. He highlighted multi‑targeting cell designs that improve specificity and reduce disease escape,...
Biogen Seeks Darzalex Rivalry in China for Multiple Myeloma with Felzartamab Deal
Biogen has secured exclusive rights to TJ Biopharma’s anti‑CD38 antibody felzartamab in Greater China for up to $850 million, including control of a pending biologics licence application for relapsed and refractory multiple myeloma. The drug will be manufactured domestically at TJ...
Voices: Brittney Jaskowiak, SVP, Client Success, Dragonfly Health
Dragonfly Health is positioning its integrated DME‑and‑pharmacy platform as a strategic solution for hospice providers facing mounting pressure to improve visibility, cut operational friction, and leverage utilization data. By unifying two of hospice’s largest cost centers under a single, technology‑driven...
Novartis Pulls Pluvicto Prostate Cancer Label Expansion Filing in the EU
Novartis has pulled its European Medicines Agency (EMA) application to extend the label of Pluvicto, its lutetium‑177 PSMA‑targeted radioligand therapy, into earlier‑stage prostate cancer. The drug already received approval for this indication in the United States and the United Kingdom,...
Disciplinary Inquiry Resumes Into Doctor’s Alleged Baby Blunder 16 Years Ago
The Hong Kong Medical Council resumed a disciplinary inquiry into Dr. Sit Sou‑chi for allegedly failing to promptly investigate newborn Li Yuanjian’s seizures in December 2009, a lapse that left the child with cerebral palsy and quadriplegia. After a public...
How AI Is Changing Healthcare Compliance and Why Most Apps Aren’t Ready
Artificial intelligence is now a staple in healthcare compliance, powering automated audit‑trail analysis, policy management, continuous risk scoring, and rapid incident detection. However, once AI models ingest protected health information, they fall under HIPAA, state privacy statutes, and breach‑notification rules,...
Flexibility Is Key to Future-Ready Hospital Design
Hospital leaders are moving away from permanently installing equipment toward modular, reconfigurable spaces that can evolve with emerging technologies. Cleveland Clinic CIO Sarah Hatchett emphasizes that flexibility enables rapid adoption of AI, digital health tools, and new treatment modalities. The...
Reimagining the Smart Hospital, Cleveland Clinic Style
Cleveland Clinic’s chief information officer, Sarah Hatchett, says a truly smart hospital hinges on orchestrating a seamless, longitudinal patient journey rather than simply installing the latest devices. At HIMSS26, the health system showcased how AI‑driven analytics pull in pre‑admission data...
Codeine: Why One Person’s Painkiller Can Be Another Person’s Problem
Codeine, a weak opioid commonly sold OTC in the UK, is metabolised into morphine by the liver enzyme CYP2D6, creating wide variability in its effectiveness and safety. Genetic differences mean ultra‑rapid metabolisers (1‑2% of the population) can experience dangerously high...
Medicare AI Prior Authorization Pilot Delaying Care in Washington: Report
A Medicare pilot that uses artificial‑intelligence‑driven prior authorizations—known as the WISeR model—has stretched approval times in Washington from roughly two weeks to four‑to‑eight weeks. The delay, documented by the Washington State Hospital Association, is forcing providers to add staff and...